Sanofi, CD&R in exclusive talks over sale of USD17 billion Opella MD Bureau22 Oct 2024 10:00 AM ISTSanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024
Sanofi closes deal for consumer health unit Opella: Report MD Bureau21 Oct 2024 1:18 PM ISTThe breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the country
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Bidding war for Sanofi's Opella intensifies as PAI raises bid MD Bureau18 Oct 2024 9:45 AM ISTAll candidates had the same opportunity to submit their best offers within the process deadline, Sanofi said.
Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report MD Bureau17 Oct 2024 3:13 PM ISTNovavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.
Pfizer Hemophilia drug Hympavzi Receives USFDA Approval MD Bureau14 Oct 2024 2:08 PM ISTPfizer announced on Friday that the U.S. Food and Drug Administration has granted approval for its once-weekly injection designed to treat the two...
GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits Ruchika Sharma10 Oct 2024 6:17 PM ISTNew York: Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S. state courts,...
Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Medical Bulletin 07/ October/ 2024 Dr. Bhumika Maikhuri7 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Want to Prevent Back Pain? Reduce Sitting TimeA new study from the University of Turku in Finland showed...
WHO recommends maternal vaccine and antibody shot for preventing RSV in infants Dr. Bhumika Maikhuri7 Oct 2024 8:45 AM ISTThe World Health Organization recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial...
FDA approves first biologic treatment for COPD Dr. Kamal Kant Kohli3 Oct 2024 7:30 AM ISTThe US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary...
Sanofi, Regeneron get USFDA nod for Dupixent for COPD Ruchika Sharma29 Sept 2024 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...
